Article

Signal transduction by vascular endothelial growth factor receptors

Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Biochemical Journal (Impact Factor: 4.4). 07/2011; 437(2):169-83. DOI: 10.1042/BJ20110301
Source: PubMed

ABSTRACT

VEGFs (vascular endothelial growth factors) control vascular development during embryogenesis and the function of blood vessels and lymphatic vessels in the adult. There are five related mammalian ligands, which act through three receptor tyrosine kinases. Signalling is modulated through neuropilins, which act as VEGF co-receptors. Heparan sulfate and integrins are also important modulators of VEGF signalling. Therapeutic agents that interfere with VEGF signalling have been developed with the aim of decreasing angiogenesis in diseases that involve tissue growth and inflammation, such as cancer. The present review will outline the current understanding and consequent biology of VEGF receptor signalling.

Full-text preview

Available from: biochemj.org
    • "VEGF also binds to non-tyrosine-kinase receptors of the neuropilinfamily , NRP1 and NRP2, which act as co-receptors of the other VEGFR [1]. After VEGF binding, tyrosine-kinase receptors dimerize, followed by conformational changes that finally lead to the activation of a downstream signaling cascade [1]. For example, phosphorylation of the tyrosineresidue 1214 in the VEGFR-2 is known to activate signaling cascades for actin reorganization in endothelial cells [2]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Over the last decade, our understanding of the vascular endothelial growth factor (VEGF) has rapidly increased, becoming the focus of many investigations the world over. Besides its classical role in the vascular system, VEGF was also identified as a factor affecting the nervous system. One structure that responds to VEGF-signaling is the axonal growth cone, the correct behavior of which is essential for the development of a properly working neuronal network. It navigates growing axons to their final destination and helps to create proper synapses at predetermined locations. Recent data concerning the impact of VEGF on the actin cytoskeleton of neuronal growth cones are discussed and new findings of VEGF-signaling in regard to actin dynamics are specified. Overall, we describe the role of VEGF regulation of cofilin and the Arp2/3-complex in axonal growth cones.
    No preview · Article · Jun 2015 · Current neurovascular research
  • Source
    • "Angiogenesis is important in tumor growth and metastasis . It is primarily driven by VEGF-A (Vascular Endothelial Growth Factor) [124], acting through binding on VEGF Re- ceptor-2 (VEGFR-2) [125], the latter expressed on endothelial cells. VEGFR-2 engagement by VEGF results in endothelial cell proliferation, migration and motility [126], while VEGFR-1 is thought to act as a decoy receptor. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Breast carcinoma is currently considered as a group of diseases, differing not only in histopathologic phenotype, as indicated by histologic type and grade, but also in their protein, genetic and epigenetic molecular profile. The standard of care indicates that the core information for patient management includes data on Estrogen Receptor (ER), Progesterone Receptor (PgR) and Human Epidermal Growth Factor Receptor 2 (HER2), while there is an emerging role for the proliferation marker Ki67. These indices can be provided even in low resource settings and are indispensable for prognostication and therapeutic patient management. With the progress in molecular and translational research, there is a growing body of information on the molecular subtypes of breast carcinoma and their significance, and multigene signature assays are used to dictate prognosis and guide therapeutics in high resource settings. In addition, several cellular pathways involved in tumor growth and spread are dissected and targeted in clinical trials. Among these are the p53, RB, PI3K/Akt/mTOR and Ras/MAPK pathways, alterations associated with genetic instability and epigenetic alterations including histone methylation and acetylation, DNA methylation and microRNAs expression. The tumor immune microenvironment, including the tumor infiltrating lymphocytes (TILs) is attracting significant research interest. This review summarizes the mechanisms of function of the above factors in breast tumorigenesis with emphasis on their prognostic and predictive value and their use as therapeutic targets.
    Full-text · Article · Jan 2015 · Current molecular pharmacology
  • Source
    • "Vascular endothelial growth factor A (VEGFA, VEGF) is a potent inducer of blood vessel growth, but also has essential roles in neurodevelopment (Mackenzie and Ruhrberg, 2012). In humans, VEGF is encoded by a single gene (VEGFA) of eight exons that is alternatively spliced into isoforms, the major ones containing 121, 165 and 189 amino acid residues and therefore termed VEGF 121 , VEGF 165 and VEGF 189 , respectively (Fig. 1A; Koch et al., 2011). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The vascular endothelial growth factor (VEGFA, VEGF) regulates neurovascular patterning. Alternative splicing of the Vegfa gene gives rise to three major isoforms termed VEGF121, VEGF165 and VEGF189. VEGF165 binds the transmembrane protein neuropilin 1 (NRP1) and promotes the migration, survival and axon guidance of subsets of neurons, whereas VEGF121 cannot activate NRP1-dependent neuronal responses. By contrast, the role of VEGF189 in NRP1-mediated signalling pathways has not yet been examined. Here, we have combined expression studies and in situ ligand-binding assays with the analysis of genetically altered mice and in vitro models to demonstrate that VEGF189 can bind NRP1 and promote NRP1-dependent neuronal responses. © 2015. Published by The Company of Biologists Ltd.
    Full-text · Article · Dec 2014 · Development
Show more